Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer
Nia JulianFebruary 11, 2021
Facebook0 Twitter Pinterest0 0 Likes
Previous

FDA Approves G1 Therapeutics' Cosela to Prevent Chemo Damage in Lung Cancer

Nia JulianFebruary 15, 2021
Next

CARISMA THERAPEUTICS COMPLETES SERIES B FUNDING FOR $47 MILLION TO ADVANCE DEVELOPMENT OF NOVEL CAR-MACROPHAGE IMMUNOTHERAPIES

Nia JulianJanuary 7, 2021

© 2020 Solasta Ventures. All Rights Reserved.